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Abstract  
Objective: Virtual patients (VPs) are a method of simulating clinical practice however 
little is known about their use by healthcare professionals. This study explores if, and 
how, one VP is educationally beneficial for pharmacists and pre-registration trainees to 
teach non-vitamin K oral anticoagulant (NOAC) patient counselling.     Method: The 
evaluation used a before and after questionnaire measuring self-perceived counselling 
ability; further questions considered the outcomes of VP use. Data were analysed 
using descriptive and inferential statistics; ethical approval was granted by Keele 
University.  Results: There was an average improvement in the user’s (n=94) 
self-perceived ability to conduct NOAC counselling (+10.2%). Although, there was 
variation in educational outcomes with changes in both knowledge and confidence 
reported. Some reported a decreased ability, but they were still positive towards the 
VP as it may have had a regulatory effect.  Conclusion: Most users perceived 
multiple benefits of use; more generic outcomes related to counselling skills were also 
reported. 
Introduction 
Virtual patients (VPs) are a well-established method of 
simulating clinical practice with recognised benefits of 
safety and standardisation (Douglass et al., 2013; Stevens 
et al., 2006), although they have principally only been 
assessed for use by undergraduate healthcare students 
(Al-Dahir et al., 2014; Battaglia et al., 2012; Bindoff et al., 
2014; Cavaco & Madeira, 2012; Menendez et al., 2015; 
Pereira & Cavaco, 2014; Smith & Benedict, 2015; Smith, 
Mohammad, & Benedict, 2014) and little is known about 
the use of VPs outside of a structured educational course 
and ran by qualified healthcare professionals as opposed 
to students (Richardson, White, & Chapman, 2019). VP 
applications have an established educational value in 
student groups whereby they have demonstrated uses for 
knowledge (Battaglia et al., 2012; Zlotos et al., 2016) 
competency (Bindoff et al., 2014) and performance 
(Taglieri et al., 2017). 
Studies have tended to focus on individual VP technologies 
built into well-structured undergraduate courses with a 
single outcome of relevance to a particular application, 
such as a gain in knowledge or competence; this is in part 
due to the historic user group being students enrolled on a 
course rather than registered professionals working in 
practice. Furthermore, what has not been considered is a 
fluid and individualised approach to the VP’s educational 
benefits whereby a VP may have benefits around a 
number of outcomes and types of learning dependent on 
the individual user and their practice.  
No studies have used registered pharmacists as the main 
user of a VP and so the perspectives of this user group on 
VP technology and its educational value is unknown; 
Battaglia and authors (2012) did include pharmacists in 
their study alongside students but this only accounted for 
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pharmacists as the main user group was not an aim of the 
research; furthermore the technology was static and non-
animated with a focus away from counselling but on 
medication management (Battaglia et al., 2012). Thomp-
son, White, and Chapman (2017) and Zlotos and authors 
(2016) both evaluated the use of VPs by pre-registration 
trainee pharmacists; although in both studies the VP was 
accessed as part of other education and training as part of 
the pre-registration training year rather than having a 
focus on abilities in practice. 
In an earlier systematic review, eight VP studies that used 
animated technology were evaluated and despite all of 
the applications being aimed at students or pre-
registration trainees the users, in all cases, took on the role 
of a pharmacist when using the application. This suggests 
that VPs are well-suited to simulate a pharmacist’s role 
despite this not yet being directly tested (Richardson, 
White, & Chapman, 2019). The possibility to teach 
qualified HCPs including pharmacists has been highlighted 
as a future research area by multiple studies (Bracegirdle 
& Chapman, 2010; Duff, Miller, & Bruce, 2016; Kane-Gill & 
Smithburger, 2011; Thompson, White, & Chapman, 2016; 
Thompson et al., 2017), 
Within this study, a VP application has been designed 
using animated video technology to simulate a patient 
counselling interaction (Figure 1) (Richardson, Chapman, 
& White, 2019). It uses multiple choice questions to give 
the user choice in the flow and direction of the 
consultation and it provides personalised feedback to help 
improve performance and promote reflection. The VP 
application was developed to teach and provide a practice 
opportunity for pharmacists and pre-registration trainee 
pharmacists to develop skills in non-vitamin K oral 
anticoagulant (NOAC) patient counselling. This study aims 
to explore if and how the VP is educationally beneficial for 
pharmacists and pre-registration trainee pharmacists. 
Throughout this study there is a focus on the individual 
learner and personal benefits to using the VP.   
Methods 
The VP evaluation used an online questionnaire using 
Google Forms made up of several elements and question 
types. Ethical approval from Keele University and United 
Kingdom Health Research Authority approval were 
granted prior to data collection; respondents provided 
informed consent prior to taking part. Respondents were 
registered pharmacists and pre-registration trainee 
pharmacists working in hospital and/or community 
sectors; respondents were recruited using professional 
networks from 14 sites across England. Recruitment from 
each used a convenience sample; a sample size calculation 
was not appropriate for this evaluation as a second part of 
the evaluation used qualitative methods.  
Prior to trialling the VP, respondents were asked a series of 
Likert questions regarding their current confidence and 
the likely interest in further NOAC education and training. 
These questions used 5-point Likert scales of 1 ‘not at all’ 
to 5 ‘extremely’. The questionnaire also included before 
and after tests of the user’s self-perceived ability to 
conduct different elements of NOAC counselling, this was 
based on the 11 items discussed within the National 
Institute for Health and Care Excellence guidelines for 
Figure 1: The virtual patient programme interface 
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anticoagulant counselling as being essential counselling 
points (National Institute for Health and Care Excellence, 
2014). The questions used five-point Likert scales of ‘poor’ 
to ‘excellent’ and they did not directly test knowledge but 
reported a respondent’s perception of their ability. The 
questionnaire also included 5-point Likert scales on the 
implications of and consequences for using the 
application; there was one ranking question that asked 
respondents to rank five options from the most to least 
relevant. Across the questionnaire, the Likert questions 
were based on previous evaluations of VPs from the 
literature, the scales used verbal descriptors that have 
previously been used in VP evaluations (Douglass et al., 
2013; Taglieri et al., 2017). A final, free-text, question 
asked the respondent their perspectives on the 
consequences of using the VP for patient care. 
The questionnaire data were analysed using a mixture of 
descriptive and inferential statistics. Likert data concerning 
pre-VP practice and confidence on NOAC counselling, and 
questions concerning the implications for using the VP 
were analysed descriptively via medians and interquartile 
ranges (IQR). Pre-and post-tests of self-perceived 
counselling ability were grouped together into pre- and 
post-VP scores and the average percentage change was 
calculated (Boone & Boone, 2012). The grouped data 
underwent statistical analysis using paired t-tests to 
establish whether there was a significant difference 
between the two sets of scores pre to post-VP use; T-tests 
have previously been used in similar VP evaluations (Al-
Dahir et al., 2014; Battaglia et al., 2012). The last sections 
of analysis included the responses to the ranking question 
with five outcomes being analysed using a Friedman Test 
that identified whether there was a statistical significance 
between the responses (Field, 2013). The free-text 
question on consequences for patient care was analysed 
via thematic analysis to identify key perspectives. 
Results 
Questionnaire responses were split across those from the 
hospital sector (n = 61, 64.9%) and those from the 
community sector (n = 26, 27.7%, n = 7 reported other 
sectors of practice or mixed roles) and there was a range in 
the demographics of the respondents (total respondents n 
= 94; see Supplementary Material). 
Initially respondents were asked how confident they were 
about conducting NOAC counselling using a scale of ‘not at 
all’ to ‘extremely’ and 72.4% of responses were for 
‘moderately’ and ‘quite’ confident (median ‘quite’, IQR = 1) 
(Figure 2). 
The respondents were also asked about their interest in 
learning more about NOACs and atrial fibrillation (AF) 
(from ‘not at all’ to ‘extremely’). Responses were more 
consistent for this question, with the majority of answers 
(90.5%) corresponding to ‘quite’ and ‘extremely’ (median 
‘quite’, IQR = 1). The same was true for the question about 
the potential usefulness of such training, where the 
median was ‘extremely’ and 94.7% of responses were for 
‘quite’ and ‘extremely’ (IQR = 1) (Figure 3).  
Respondents were asked to rate their perceived ability to 
counsel a patient on given sub-areas of NOAC counselling, 
these were asked before and after use of the VP. Likert 
data were grouped in to pre- and post-VP scores and 
underwent a t-test calculation. On average, respondents’  
2.1% 16.0% 30.9% 41.5% 9.6%How confident are you counsellingpatients  on NOACs for atrial fibrillation?
Not at all Slightly Moderately Quite Extremely
Figure 2: Responses to the Likert question concerning confidence in NOAC counselling 
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scores increased after VP use, with an average increase of 
10.2% (percentage change in ability pre-post VP use 
ranged from -30.3%-39.6%) (Table I), this was statistically 
significant (p < 0.001). Of the 94 respondents, 71 (75.5%) 
demonstrated an increase in self-reported ability, 17 
(18.1%) had no change and six (6.4%) had a decrease.  
Table I: Analysis of the significance of the average change 
in pre- to post-VP self-reported ability using a paired t-
test 
*CI: Confidence Interval 
Further questions asked whether respondents thought 
that the VP had changed their knowledge, their 
confidence, and whether this would result in a change in 
their practice (Figure 4). These questions used 5-point 
Likert scales of ‘strongly disagree’ to ‘strongly agree’. The 
spread of the responses for the three questions were 
similar and the median scores were identical (median 
‘quite’, IQR = 0 for knowledge, IQR = 1 for confidence and 
change of practice). The question regarding confidence 
had the lowest proportion of ‘agree’ and ‘strongly agree’ 
responses (70.2%) although this was close to the scores of 
the other two questions (72.3% knowledge, 75.5% change 
of practice). It is unclear whether there was a greater 
perceived effect of one of these outcomes over the other. 
Where there were responses that disagreed with this, they 
tended to be across all three questions.  
After using the VP, the respondents ranked five outcomes 
to indicate the way in which they perceived that it had 
impacted on their learning and development (1 greatest 
impact to 5 smallest impact) (Figure 5). ’Change of 
knowledge’ and ‘change of confidence’ received scores 
corresponding to the largest impact (average ranking 3.3 
and 3.6 respectively) followed by a ‘development in 
generic consultation skills’ and ‘contribution of 
CPD’ (continuing professional development) (3.1 and 3.0 
respectively). Finally, the outcome with the least 
impact concerned a change of knowledge around NOACs 
more generally in other indications outside of atrial 
fibrillation (AF, AF is the indication of the patient within 
the VP simulation) (2.0).   
The significance of this result was assessed via 
a Friedman Test (Table II), which indicated that the VP 
outcomes posed to the respondents were ranked 
statistically differently,  χ2(4) = 52.175, (p = 0.000). It is 
unclear exactly where this significance lies. On an 
individual level, the majority of respondents ranked the 
385
Figure 3: Responses to two Likert questions concerning the usefulness of further learning on NOACs and the interest in 
further learning on NOACs 
Mean 95% CI* Standard deviation Significance (2-tailed)
Pre-test 42.27 40.8-43.7 7.13 -
Post-test 47.16 46.0-48.3 5.59 -
Difference pre- 
to post-VP 4.89 3.75-6.03 5.66 0.000
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Figure 4: Implications of VP use across three Likert questions 
Figure 5: The frequency of times that possible learning outcomes of the VP were ranked as having the smallest and largest 
impact on a respondent’s learning and development  
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‘[the VP] could play a significant role in improving 
counselling skills and improve skills for a particular 
subject without practicing on real patients. Improve 
confidence to talk to patients on a subject’  
[P40] 
A number of respondents also directly related the use of 
the VP to either pre-registration training or as part of CPD. 
Discussion 
Most users reported seeing a personal benefit to VP use 
via an improvement in their perceived ability, this was 
demonstrated via the measured average increase in self-
reported counselling ability pre- to post-VP, although some 
results were deviant of this. This measured improvement 
could be due to a number of possible outcomes including 
both knowledge and confidence changes as well as more 
generic outcomes regarding counselling ability. This 
includes the possibility that multiple outcomes can be 
developed at any one time from using the VP. It is not clear 
whether the VP was more likely to have an effect on any 
single particular outcome.  
The findings are significant as this is the first study to 
explicitly explore the use of this type of animated VP by 
registered pharmacists. Furthermore, the findings 
demonstrate the concept of a multi-purpose VP where 
outcomes for individuals may vary or be a blend of 
multiple. Zigmont and authors discussed that simulation 
can help individuals to set personal learning goals but this 
has not yet been explored relative to VPs specifically as a 
sub-type of simulation technology (Zigmont, Kappus, & 
Sudikoff, 2011). Equally, setting goals has previously not 
been translated to personal outcomes or implications for 
use and so these findings are fundamental to 
understanding how VPs could be used by a group of 
healthcare professionals where outcomes may not be 
standardised. Furthermore, the respondents recognised 
the potential impact of the VP to increase counselling 
standards and consequently patient care. This is 
encouraging as VP use has scarcely been linked to 
outcomes in practice, with no studies appearing to focus 
on the use of VP by healthcare professionals relative to the 
service that patients receive. 
The majority of respondents identified VP use for NOAC-
specific knowledge and confidence outcomes over other 
options, although there was very little between the two as 
they appear to be interlinked. For other users the 
important outcomes were somewhat reversed relating to 
outcomes in roughly the same order as the aver-
age rankings, but some individuals appeared to perceive 
the purpose of the VP as completely different. For 
example, some individual respondents reported a 
‘contribution to CPD’ or ‘contribution to generic 
consultation skills’ as having the greatest impact 
with ‘knowledge and confidence changes’ ranked lower 
down. ‘Contribution to CPD’ and ‘development of generic 
consultation skills’ both received a similar number 
of rankings for both the largest and smallest impacts, 
this further highlighted that different users appeared to 
perceive the purpose of the VP differently to each other.   
Finally, respondents were asked what they perceived the 
potential impact that the use of the VP would have on 
patient care. Responses included benefits for pharmacist’s 
counselling skills, both, through knowledge acquisition 
and the opportunity to practice. 
‘the virtual patient programme could help improve 
pharmacist patient counselling skills thus improving 
patient experience. It will also enable pharmacists to 
practice counselling patients enabling them to feel more 
confident in counselling patients and be more familiar 
with the process’  
[P4] 
The consequences of this learning for patient care was 
also related to patient safety and compliance: 
‘If all new medicines especially high-risk medicines like 
DOACs [direct oral anticoagulants] and VKAs [vitamin K 
antagonists] were explained in this manner it would have 
a hugely positive effect on patient adherence and safety’  
[P11] 
A number of respondents also commented on the 
usefulness of practical experience for conducting this type 






Table II: Results of a Freidman test for analysing the 
results of a ranking question concerning the purposes of 
the VP  
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and non-subject specific benefits. Users were positive 
about the implications of using the VP with a number of 
learning outcomes identified, although these varied 
between individuals. It is possible that there are a number 
of educational benefits for users of the VP with no single 
overarching purpose applicable to all. 
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